Similar articles

• [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].

  Haumonté MT, Hoerdt HP. Haumonté MT, et al. Ann Med Psychol (Paris). 1972 Feb;1(2):277-83. Ann Med Psychol (Paris). 1972. PMID: 5051257 French. No abstract available.
• [Clinical experience with fluphenazine decanoate in psychoses].

  Náhunek K, Rodová A, Svestka J. Náhunek K, et al. Act Nerv Super (Praha). 1970 Jan 12;12(1):47-9. Act Nerv Super (Praha). 1970. PMID: 5460564 Czech. No abstract available.
• Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects.

  van Praag HM, Dols LC. van Praag HM, et al. Am J Psychiatry. 1973 Jul;130(7):801-4. doi: 10.1176/ajp.130.7.801. Am J Psychiatry. 1973. PMID: 4576449 Clinical Trial. No abstract available.
• Depot fluphenazine: risk/benefit ratio.

  Glazer WM. Glazer WM. J Clin Psychiatry. 1984 May;45(5 Pt 2):28-35. J Clin Psychiatry. 1984. PMID: 6370986 Review.
• The use of depot neuroleptics: clinical experience in the United States.

  Kane JM. Kane JM. J Clin Psychiatry. 1984 May;45(5 Pt 2):5-12. J Clin Psychiatry. 1984. PMID: 6370987 Review.